Qlucore AB (public) (“Qlucore” or “Company”) has today received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares will be 5th November 2021. Trading will be done with the ticker QCORE. “This paves the way for a new phase in […]
FORT LAUDERDALE, Fla. — Gemini Bioproducts, LLC (“GeminiBio”), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids, announced today that it has secured financing from BroadOak Capital Partners, LLC (“BroadOak”), a boutique direct investment and advisory firm focused on life science research tools and diagnostics. The transaction with BroadOak provides GeminiBio additional […]
Funds to drive commercial expansion as growing number of facilities bring genomics into communities worldwide ST. LOUIS, MO — PierianDx, the global leader in clinical genomics knowledge, announced that it closed on $30 million of new growth capital including equity financing and a term loan facility, which includes access to additional tranches for up to […]
Technology increases the amount and quality of data that can be efficiently and cost-effectively obtained from a small DNA sample Manufacturing of the first product from a new technology platform is underway with expected commercial availability in early 2022; early access programs with renowned research institutions are ongoing CAMBRIDGE, United Kingdom — Cambridge Epigenetix (CEGX), […]
Cambridge, UK: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced today that it has closed a $40 million (circa £30 million) investment round. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms. Sphere Fluidics […]
New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $280M SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing led by Coatue Management […]
SAN DIEGO & PHILADELPHIA—LLR Partners today announced an investment in Genesee Scientific, a manufacturer and distributor of products to global life science markets. The partnership will help enable Genesee’s continued growth through investment in its leading product portfolio, scaling of its national footprint and continued excellence in serving its laboratory customers. Genesee Scientific was founded in 1995 […]
SAN DIEGO — Molecular Assemblies, Inc., today announced that it has been awarded a $250,000 Phase I Small Business Innovation Research (SBIR) grant (Award No. R43HG011679) from the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH). The grant supports Molecular Assemblies’ development of a fully enzymatic synthesis cycle for […]
RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures Financing proceeds will support continued commercial expansion, development of new applications, and product development. Burlington, MA – October 18th, 2021 RedShift BioAnalytics Inc. (RedShiftBioⓇ), a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules, announced today the closing of its […]
ALBUQUERQUE, N.M. Armonica Technologies, Inc., a biotechnology company developing a high throughput, direct long-read DNA sequencing technology, announced that it has raised $2M in new funding. The financing included Hamamatsu Photonics K.K. and current investors Cottonwood Technology Fund, Sun Mountain Capital and Tramway Venture Partners. The funding will support further feasibility demonstration of company’s sequencing technology. Akira […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
